
Skin Glow (GHK-Cu) — 50 mg
A copper–tripeptide complex used in laboratory models concerning signalling and the extracellular matrix.
50 mg
Peptides and combinations studied in preclinical signalling and tissue models. Nothing in this category constitutes a therapeutic indication or a recommendation for personal use.

A copper–tripeptide complex used in laboratory models concerning signalling and the extracellular matrix.
50 mg

A 100 mg configuration of the GHK-Cu complex for laboratory research use only.
100 mg

A synthetic 15-amino-acid peptide investigated in preclinical tissue-signalling models.
5 mg

A 10 mg configuration of BPC-157, listed solely for assessment and preclinical research.
10 mg

A commercial material associated with thymosin beta-4-derived sequences. Sequence and identity must be verified for every batch.
5 mg

A 10 mg configuration; the declared sequence and identification method must be confirmed in the batch documentation.
10 mg

A declared multi-component blend. The identity and quantity of every component must be supported separately by batch documentation.
BPC-157 10 mg + GHK-Cu 50 mg + TB-500 5 mg

A declared four-component blend. Commercial release requires individual and combined composition verification.
BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg + KPV 10 mg
Scientific context for Skin Glow (GHK-Cu), evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for BPC-157, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for TB-500, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for GLOW, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for KLOW, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →The content and catalogue are intended for eligible professionals, laboratories and research organisations.
Read the full noticeReceive a code for the first order that passes eligibility and legal-availability checks.